![Helen Heslop](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Helen Heslop
Director/Board Member at The Leukemia & Lymphoma Society, Inc.
Helen Heslop active positions
Companies | Position | Start | End |
---|---|---|---|
The Leukemia & Lymphoma Society, Inc.
![]() The Leukemia & Lymphoma Society, Inc. Miscellaneous Commercial ServicesCommercial Services The Leukemia & Lymphoma Society, Inc. operates as the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. The firm provides treatment for , lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. It identifies and funds the most promising blood cancer research projects and forges partnerships with academic institutions, biotechnology and pharmaceutical companies to accelerate the development of new therapies. The company is headquartered in Rye Brook, NY. | Director/Board Member | 30/06/2023 | - |
Dan L. Duncan Comprehensive Cancer Center | Corporate Officer/Principal | - | - |
Center For Cell & Gene Therapy | Director/Board Member | - | - |
Career history of Helen Heslop
Former positions of Helen Heslop
Companies | Position | Start | End |
---|---|---|---|
ALLOVIR, INC. | Founder | 31/07/2013 | - |
Statistics
International
United States | 5 |
Operational
Founder | 2 |
Director/Board Member | 2 |
Corporate Officer/Principal | 1 |
Sectoral
Health Technology | 2 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
ALLOVIR, INC. | Health Technology |
Private companies | 3 |
---|---|
The Leukemia & Lymphoma Society, Inc.
![]() The Leukemia & Lymphoma Society, Inc. Miscellaneous Commercial ServicesCommercial Services The Leukemia & Lymphoma Society, Inc. operates as the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. The firm provides treatment for , lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. It identifies and funds the most promising blood cancer research projects and forges partnerships with academic institutions, biotechnology and pharmaceutical companies to accelerate the development of new therapies. The company is headquartered in Rye Brook, NY. | Commercial Services |
Dan L. Duncan Comprehensive Cancer Center | |
Center For Cell & Gene Therapy |
- Stock Market
- Insiders
- Helen Heslop
- Experience